Doctor profile · Federal record

Dr. Lori Hemrock, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Warren, OH

  • NPI 1073517835
  • Accepts Medicare
  • MIPS 89.4 / 100 · 2023
  • 28 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
1745 Niles Cortland RD Ne Ste 5
Warren, OH 444846046
(330) 856-8600
Additional location
835 Southwestern Run
Youngstown, OH 445143688
(330) 318-1100
fax (330) 318-1111
Mailing address
Po Box 786536
Philadelphia, PA 191786536

Credentials & registration

NPPES · NUCC
NPI registered
June 2005 — 21 yrs on file
Profile last updated
November 15, 2018
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Ohio #35-08-4208-H
Medicaid
OH #2483834

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1073517835. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
57,309
Distinct HCPCS
10
Medicare allowed
$514,773
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 16,830 16 $0
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 16,300 16 $3
J0897 Injection, denosumab, 1 mg 9,660 19 $22
J0185 Injection, aprepitant, 1 mg 6,110 13 $2
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,897 54 $0
J1626 Injection, granisetron hydrochloride, 100 mcg 1,020 16 $0
J2469 Injection, palonosetron hcl, 25 mcg 540 16 $1
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 513 53 $26
99215 Established patient office or other outpatient visit, 40-54 minutes 491 191 $165
96372 Injection of drug or substance under skin or into muscle 425 58 $13

In context: peer comparison

Among 3 peers in this city , average services per provider: 1,982. This provider delivers 29× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,116
Transactions
75
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Celgene Corporation 5 $342.56
ABBVIE INC. 11 $227.45
PFIZER INC. 15 $208.44
AstraZeneca Pharmaceuticals LP 7 $135.05
Astellas Pharma US Inc 6 $115.33
Novartis Pharmaceuticals Corporation 5 $108.80
Janssen Biotech, Inc. 4 $92.96
Genentech USA, Inc. 4 $83.41
Daiichi Sankyo Inc. 3 $69.36
Incyte Corporation 3 $67.95
GlaxoSmithKline, LLC. 3 $63.53
Acrotech Biopharma Inc. 2 $57.18
Merck Sharp & Dohme LLC 2 $50.31
Tempus AI, Inc 2 $46.35
Aveo Pharmaceuticals, Inc. 3 $46.18

By nature of payment

Food and Beverage
$2,053
Education
$62

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,460
Patients
417
Total drug cost
$1,874,161
Drug Type Claims Patients Total cost
Anastrozole Generic 379 91 $13,117
Prednisone Generic 168 60 $844
Ondansetron Hcl Generic 127 54 $2,037
Gabapentin Generic 123 29 $1,947
Pantoprazole Sodium Generic 110 39 $1,191
Letrozole Generic 72 21 $3,593
Tamoxifen Citrate Generic 66 19 $3,164
Eliquis (Apixaban) Brand 65 16 $46,759
Hydroxyurea Generic 58 13 $1,902
Jakafi (Ruxolitinib Phosphate) Brand 53 0 $912,004

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Lori Hemrock's medical specialty?
Dr. Lori Hemrock practices Hematology & Oncology Physician in Warren, OH.
Where does Dr. Lori Hemrock practice?
Dr. Lori Hemrock practices at 1745 Niles Cortland RD Ne Ste 5, Warren, OH 444846046. Office phone: 3308568600.
What is Dr. Lori Hemrock's NPI?
Dr. Lori Hemrock's National Provider Identifier (NPI) is 1073517835, issued by NPPES.
Does Dr. Lori Hemrock accept Medicare assignment?
Yes. Dr. Lori Hemrock accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lori Hemrock commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.